A Study of Pharmacokinetics, Safety and Tolerability of Dimolegin (DD217)
Clinical trial NCT05181241 · COMPLETED
Trial details
- NCT number
- NCT05181241
- Sponsor
- PharmaDiall Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-25
- Primary completion
- 2017-12-25
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.